SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-004505
Filing Date
2024-01-18
Accepted
2024-01-18 16:15:23
Documents
15
Period of Report
2024-01-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea191817-8k_adialpharma.htm   iXBRL 8-K 41059
2 STATEMENT OF WORK #2, DATED JANUARY 17, 2024, TO MASTER SERVICES AGREEMENT BETWE ea191817ex10-2_adialpharma.htm EX-10.2 31001
3 PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC ea191817ex99-1_adialpharma.htm EX-99.1 13059
4 GRAPHIC ex99-1_001.jpg GRAPHIC 3998
  Complete submission text file 0001213900-24-004505.txt   277964

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE adil-20240117.xsd EX-101.SCH 3024
6 XBRL LABEL FILE adil-20240117_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE adil-20240117_pre.xml EX-101.PRE 22365
9 EXTRACTED XBRL INSTANCE DOCUMENT ea191817-8k_adialpharma_htm.xml XML 3395
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 24541981
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)